Capsules

P: Tested on humans for the first time, trifluoroethyl vinyl ether turned out to be a promising new anesthetic. Product of 15 years research by Dr. John C. Krantz Jr., Johns Hopkins pharmacology professor, the fluorinated ether puts a patient to sleep in 27 seconds (a standard ether takes up to five minutes), has an agreeable odor and a high boiling point that should make it useful in warm climates. Biggest advantage: not readily combustible, it will reduce the danger of disastrous operating-room explosions.

P: Strong Cobb & Co. of Cleveland announced a new barbiturate which in overlarge doses will turn the stomachs of "goofball" addicts and would-be suicides. Developed by Drs. Theodore Koppanyi and Joseph Fazekas of Washington, D.C., the pills contain standard barbiturates and an added safety factor, pentylenetetrazol. A powerful nerve stimulant, the safety factor counteracts the depressant effect of too much barbiturate, and long before the goofball addict drifts into euphoria or the would-be suicide passes out, pentylenetetrazol causes the unhappy user to vomit his medicine.

P: The cross dentists bear is that patients fear and dislike them, a group of psychiatrists told the California State Dental Association. Further conclusions of the psychiatrists: 1) dentists sometimes react to their patients' antagonism by causing them unnecessary pain; 2) just as the man in the chair needs a break now & then to spit, so the dentist needs a break occasionally--to spit or even swear a little, and thus relieve his own tensions.

This file is automatically generated by a robot program, so reader's discretion is required.